Lyell Immunopharma (LYEL) Current Assets (2020 - 2026)
Lyell Immunopharma's Current Assets came in at $213.54 million for Q2 2026, down 24.3% from $282.21 million a year earlier and down 20.1% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma's Current Assets was $260.94 million, down 31.3% from FY2024.
- Current Assets has declined in each of the last three years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Going back by year, Current Assets was $379.59 million in FY2024 (-31.6%), $554.69 million in FY2023 (-14.8%), $651.3 million in FY2022 (+4.0%) and $626.29 million in FY2021 (+1.4%).
- The Q2 2026 figure represents the lowest quarterly Current Assets in data going back to Q4 2020.
- Year-over-year, Current Assets has declined for 14 consecutive quarters, with an average decline of 29.6% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q3 2022 (growth of 4.5%), and the weakest in Q2 2025 (a decline of 43.5%).
- Business Quant data shows LYEL's Current Assets at $267.3 million (Q1 2026), $260.94 million (Q4 2025) and $328.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Lyell Immunopharma | 227.89 Mn | 227.89 Mn | - | 213.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 213.54 Mn |
| Mar 31, 2026 | 267.30 Mn |
| Dec 31, 2025 | 260.94 Mn |
| Sep 30, 2025 | 328.20 Mn |
| Jun 30, 2025 | 282.21 Mn |
| Mar 31, 2025 | 309.18 Mn |
| Dec 31, 2024 | 379.59 Mn |
| Sep 30, 2024 | 450.05 Mn |
| Jun 30, 2024 | 499.82 Mn |
| Mar 31, 2024 | 534.17 Mn |
| Dec 31, 2023 | 554.69 Mn |
| Sep 30, 2023 | 586.85 Mn |
| Jun 30, 2023 | 606.41 Mn |
| Mar 31, 2023 | 624.40 Mn |
| Dec 31, 2022 | 651.30 Mn |
| Sep 30, 2022 | 659.75 Mn |
| Jun 30, 2022 | 666.78 Mn |
| Mar 31, 2022 | 625.71 Mn |
| Dec 31, 2021 | 626.29 Mn |
| Sep 30, 2021 | 631.15 Mn |
API Access
Lyell Immunopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();